Gilead Sciences (NASDAQ:GILD) Given New $105.00 Price Target at Wells Fargo & Company
Gilead Sciences (NASDAQ:GILD – Free Report) had its price objective lifted by Wells Fargo & Company from $100.00 to $105.00 in a report issued on Thursday morning,Benzinga reports. The firm currently has an overweight rating on the biopharmaceutical company’s stock. A number of other equities research analysts also recently weighed in on the company. Needham […]
More Stories
Western Asset Inflation-Linked Opportunities & Income Fund (WIW) to Issue Monthly Dividend of $0.06 on December 31st
Western Asset Inflation-Linked Opportunities & Income Fund (NYSE:WIW – Get Free Report) announced a monthly dividend on Monday, November 25th,NASDAQ...
Eaton Vance Tax-Managed Diversified Equity Income Fund (ETY) To Go Ex-Dividend on December 23rd
Eaton Vance Tax-Managed Diversified Equity Income Fund (NYSE:ETY – Get Free Report) announced a monthly dividend on Monday, December 2nd,NASDAQ...
Financial Institutions (NASDAQ:FISI) Coverage Initiated by Analysts at Piper Sandler
Piper Sandler initiated coverage on shares of Financial Institutions (NASDAQ:FISI – Free Report) in a research note released on Friday...
Radian Group Inc. (NYSE:RDN) Enters into Amendment to Master Repurchase Agreement with JPMorgan
Radian Group Inc., a financial services company based in Wayne, Pennsylvania, made public a significant development on December 13, 2024,...
FuelCell Energy (NASDAQ:FCEL) Price Target Raised to $12.00 at TD Cowen
FuelCell Energy (NASDAQ:FCEL – Free Report) had its price objective boosted by TD Cowen from $2.00 to $12.00 in a...
Arrow Financial (NASDAQ:AROW) Now Covered by Analysts at Piper Sandler
Piper Sandler initiated coverage on shares of Arrow Financial (NASDAQ:AROW – Free Report) in a research report released on Friday...